- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Attorney
Court
Firm
Judge
Party
Displaying 54-68 of
40,079 results
No. 256
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 256 (D.Del. Apr. 2, 2024)
|
|
Cite Document
No. 253
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 253 (D.Del. Mar. 27, 2024)
|
|
Cite Document
No. 152
Document
Bluestar Genomics v. Song et al, 4:21-cv-04507, No. 152 (N.D.Cal. Mar. 25, 2024)
|
|
Cite Document
No. 242
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 242 (D.Del. Mar. 6, 2024)
|
|
Cite Document
No. 38
Document
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al., 1:23-cv-01103, No. 38 (D.Del. Mar. 6, 2024)
|
|
Cite Document
No. 148
Document
Bluestar Genomics v. Song et al, 4:21-cv-04507, No. 148 (N.D.Cal. Feb. 29, 2024)
|
|
Cite Document
No. 234
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 234 (D.Del. Feb. 27, 2024)
|
|
Cite Document
No. 235
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 235 (D.Del. Feb. 27, 2024)
|
|
Cite Document
No. 220
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 220 (D.Del. Feb. 12, 2024)
|
|
Cite Document
No. 28
Document
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al., 1:23-cv-01103, No. 28 (D.Del. Feb. 12, 2024)
|
|
Cite Document
No. 211
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 211 (D.Del. Jan. 25, 2024)
|
|
Cite Document
No. 140
Document
Bluestar Genomics v. Song et al, 4:21-cv-04507, No. 140 (N.D.Cal. Jan. 4, 2024)
|
|
Cite Document
No. 139
Document
Bluestar Genomics v. Song et al, 4:21-cv-04507, No. 139 (N.D.Cal. Dec. 21, 2023)
|
|
Cite Document
No. 203
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 203 (D.Del. Dec. 15, 2023)
|
|
Cite Document
No. 198
Document
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation, 1:21-md-03017, No. 198 (D.Del. Nov. 21, 2023)
|
|
Cite Document
